Valuation: Vineet Laboratories Limited

Market Cap 558M 5.85M 5.07M 4.75M 4.33M 8.15M 8.28M 55.95M 21.84M 279M 21.96M 21.48M 932M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10.01M 8.68M 8.14M 7.42M 13.96M 14.18M 95.79M 37.4M 478M 37.59M 36.77M 1.6B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
Jul. 21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
May. 29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
Feb. 14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Feb. 07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
Dec. 17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
Nov. 27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
Nov. 27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
Nov. 24 Vineet Laboratories to consider rights issue RE
Nov. 08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
25-09-16 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
25-07-22 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-12 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
24-11-13 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day-1.39%
1 week-1.44%
Current month-3.00%
1 month+19.34%
3 months+5.40%
6 months+25.91%
Current year+4.51%
1 week 35.01
Extreme 35.01
39.94
1 month 32.35
Extreme 32.35
40.2
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
94.95
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 2020-12-31
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 2016-11-09
Director/Board Member 76 2016-11-09
Chairman 73 2020-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-1.44%+13.86%-32.26% 7.85M
-0.86%+1.45%+83.08%+124.76% 1,088B
-0.04%+1.56%+49.64%+50.48% 629B
+0.42%+2.53%+24.11%+64.21% 440B
-0.88%-0.66%+45.09%+36.79% 359B
-0.37%-1.15%+26.89%+36.10% 291B
+0.05%-1.20%+2.31%+5.34% 245B
-0.01%+2.88%+43.96%+59.61% 225B
-0.42%+1.58%-8.48%-51.84% 204B
+0.40%+4.36%+13.67%+71.02% 168B
Average -0.26%+1.14%+29.41%+36.42% 364.92B
Weighted average by Cap. -0.29%+1.93%+45.82%+64.53%

Financials

2024 2025
Net sales 1.51K 15.82 13.71 12.85 11.72 22.05 22.4 151.34 59.08 755.69 59.38 58.1 2.52K 769.53 8.06 6.99 6.55 5.97 11.24 11.42 77.14 30.12 385.21 30.27 29.62 1.29K
Net income 10.27M 108K 93.28K 87.45K 79.73K 150K 152K 1.03M 402K 5.14M 404K 395K 17.15M -202M -2.12M -1.83M -1.72M -1.57M -2.95M -3M -20.24M -7.9M -101M -7.94M -7.77M -337M
Net Debt 441M 4.62M 4M 3.75M 3.42M 6.44M 6.54M 44.18M 17.25M 221M 17.34M 16.96M 736M 397M 4.16M 3.61M 3.38M 3.09M 5.8M 5.9M 39.84M 15.55M 199M 15.63M 15.29M 664M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
26-08-13 38.44 -1.39% 83,321
26-08-12 ₹38.98 +4.14% 73,758
26-08-11 ₹37.43 +4.99% 41,991
26-08-10 ₹35.65 -3.62% 65,828
26-08-07 ₹36.99 -4.42% 73,360
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock